🟢 HCW Biologics is trading 8.91% up today in pre-market as broad risk-on rebound lifts U.S. equities

HCW Biologics is trading 8.91% up at $2.19 as a broad risk-on rebound lifts U.S. equities in pre-market trading.

• No new company-specific announcement or earnings release for September 17, 2026, was identified.
• The latest company news remains the September 8 Akron Biotech distribution agreement.
• Nasdaq futures are up 1.16%, while biotechnology weakness is stabilizing after the September 16 selloff.